olympia: adjuvant olaparib following chemo significantly improves idfs
Published 3 years ago • 132 plays • Length 2:58Download video MP4
Download video MP3
Similar videos
-
2:44
olympia: adjuvant olaparib in gbrcam, her2-negative, high-risk, early breast cancer
-
5:49
perspectives on the olympia study of adjuvant olaparib in early breast cancer | nadine tung
-
5:00
olympia: adjuvant olaparib delays recurrence of brca-mutant breast cancer | judy garber
-
6:28
quality of life results from olympia
-
8:09
olaparib improves disease-free survival in high-risk early-stage her2-negative breast cancer wit...
-
2:30
monarche: abemaciclib and adjuvant endocrine therapy for high-risk hr early breast cancer
-
2:18
the importance of the olympia trial for breast cancer patients
-
3:05
exploring the use of olaparib in advanced breast cancer
-
2:55
olaparib considerably increases pfs in ovarian cancer
-
3:09
breast cancer breakthrough - prof andrew tutt on the olympia trial
-
2:38
olaparib durvalumab as a chemotherapy-free maintenance strategy in platinum treated advanced tnbc
-
6:16
asco 2021 - highlights on shifting parpi to early breast cancer: the olympia study
-
3:37
olaparib in metastatic pancreatic cancer, the polo trial
-
1:12
monarche: adjuvant abemaciclib in hr breast cancer
-
1:57
7-year os from solo1: sustained benefit with maintenance olaparib
-
0:31
revolutionary cancer breakthrough - olaparib - life saving drug for brca tnbc
-
1:00
olaparib added to standard treatment boosts survival in patients with inherited brca mutations
-
0:40
dr. willmott on fda approval of maintenance olaparib in ovarian cancer
-
1:54
apollo: olaparib in pancreatic cancer with a brca1/2 or palb2 mutation